• This record comes from PubMed

Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes

. 2018 ; 9 () : 918. [epub] 20180713

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection

Document type Journal Article

Substance P (SP) is a neuropeptide engaged in the signal transmission of neural C fibers afferents in the myocardium. The actions of SP in the heart are extensive and they are mediated by the neurokinin 1 receptor (NK1R), a member of the tachykinin subfamily of G-protein coupled receptors. The receptors have been found in the heart, but to our knowledge, their exact localization in the heart has not been described yet. Here, we investigated the presence of NK1R protein in separate rat heart compartments by means of western blot and its tissue distribution by means of immunofluorescence. Specificity of NK1R immunolabeling was controlled by preabsorption of the antiserum with its corresponding peptide. Additionally, we investigated abundance of gene for NK1R in separated heart chambers by means of quantitative real-time PCR (RT-PCR). Relative abundance of NK1R mRNA was expressed as a ratio of target gene Cq value to Cq value of control gene - beta-actin. Finally, we studied abundance of NK1R mRNA in different cell types of heart isolated by laser capture microdissection. Immunofluorescence showed NK1R immunoreactivity on the surface of some intracardiac neurons and smooth muscle cells of coronary vessels. The results of quantitative RT-PCR indicate abundance of mRNA for NK1R in all heart chambers with highest level in the left atrium. The presence of NK1R mRNA was detected in some samples of dissected intracardiac neurons, but not in cardiomyocytes or smooth muscle cells of coronary vessels. In the course of long-term diabetes, a significant downregulation of the NK1R mRNA was seen in the right atrium and upregulation in the right ventricle 53 weeks after the induction of diabetes. Our results indicate localization of NK1R in some intracardiac neurons and smooth muscle cells. Impaired transcription of the NK1R gene in the diabetic heart may be induced by unidentified genes or factors involved in the development of diabetic cardiomyopathy.

See more in PubMed

Boer P. A., Rossi Cde L., Mesquita F. F., Gontijo J. A. (2011). Early potential impairment of renal sensory nerves in streptozotocin-induced diabetic rats: role of neurokinin receptors. Nephrol. Dial. Transplant. 26 823–832. 10.1093/ndt/gfq512 PubMed DOI

Brain S. D., Cox H. M. (2006). Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br. J. Pharmacol. 147(Suppl. 1), S202–S211. 10.1038/sj.bjp.0706461 PubMed DOI PMC

Burnstock G. (2013). Cotransmission in the autonomic nervous system. Handb. Clin. Neurol. 117 23–35. 10.1016/B978-0-444-53491-0.00003-1 PubMed DOI

Cai W. Q., Bodin P., Loesch A., Sexton A., Burnstock G. (1993). Endothelium of human umbilical blood vessels: ultrastructural immunolocalization of neuropeptides. J. Vasc. Res. 30 348–355. 10.1159/000159017 PubMed DOI

Chang V. T., Yook C., Rameshwar P. (2013). Synergism between fibronectin and transforming growth factor-beta1 in the production of substance P in monocytes of patients with myelofibrosis. Leuk. Lymphoma 54 631–638. 10.3109/10428194.2012.722218 PubMed DOI

Chiao H., Caldwell R. W. (1995). Local cardiac effects of substance P: roles of acetylcholine and noradrenaline. Br. J. Pharmacol. 114 283–288. 10.1111/j.1476-5381.1995.tb13224.x PubMed DOI PMC

Chottova Dvorakova M., Kuncova J., Pfeil U., McGregor G. P., Sviglerova J., Slavikova J., et al. (2005). Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats. Neuroscience 134 51–58. 10.1016/j.neuroscience.2005.03.058 PubMed DOI

Chottova Dvorakova M., Wiegand S., Pesta M., Slavikova J., Grau V., Reischig J., et al. (2008). Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes. Neuroscience 151 1016–1028. 10.1016/j.neuroscience.2007.07.069 PubMed DOI

Church D. J., Arkinstall S. J., Vallotton M. B., Chollet A., Kawashima E., Lang U. (1996). Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes. Am. J. Physiol. 270(3 Pt 2), H935–H944. 10.1152/ajpheart.1996.270.3.H935 PubMed DOI

Corbett E. K., Sinfield J. K., McWilliam P. N., Deuchars J., Batten T. F. (2005). Differential expression of vesicular glutamate transporters by vagal afferent terminals in rat nucleus of the solitary tract: projections from the heart preferentially express vesicular glutamate transporter 1. Neuroscience 135 133–145. 10.1016/j.neuroscience.2005.06.010 PubMed DOI

Dalsgaard C. J., Franco-Cereceda A., Saria A., Lundberg J. M., Theodorsson-Norheim E., Hokfelt T. (1986). Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea-pig heart. Cell Tissue Res. 243 477–485. 10.1007/BF00218054 PubMed DOI

Dehlin H. M., Levick S. P. (2014). Substance P in heart failure: the good and the bad. Int. J. Cardiol. 170 270–277. 10.1016/j.ijcard.2013.11.010 PubMed DOI PMC

D’Orleans-Juste P., Dion S., Drapeau G., Regoli D. (1986). Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur. J. Pharmacol. 125 37–44. 10.1016/0014-2999(86)90081-6 PubMed DOI

Dvorakova M. C., Pfeil U., Kuncova J., Sviglerova J., Galvis G., Krasteva G., et al. (2006). Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Cell Tissue Res. 323 383–393. 10.1007/s00441-005-0001-7 PubMed DOI

Ejaz A., LoGerfo F. W., Khabbaz K., Pradhan L. (2011a). Expression of neuropeptide Y, substance P, and their receptors in the right atrium of diabetic patients. Clin. Transl. Sci. 4 346–350. 10.1111/j.1752-8062.2011.00318.x PubMed DOI PMC

Ejaz A., LoGerfo F.W., Pradhan L. (2011b). Diabetic neuropathy and heart failure: role of neuropeptides. Expert Rev. Mol. Med. 13:e26. 10.1017/s1462399411001979 PubMed DOI

Floch A., Fardin V., Cavero I. (1994). Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems. Br. J. Pharmacol. 111 759–768. 10.1111/j.1476-5381.1994.tb14803.x PubMed DOI PMC

Ho W. Z., Lai J. P., Zhu X. H., Uvaydova M., Douglas S. D. (1997). Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159 5654–5660. PubMed

Hoover D. B., Chang Y., Hancock J. C. (1998). Characterization of responses to neurokinin A in the isolated perfused guinea pig heart. Am. J. Physiol. 275 R1803–R1811. 10.1152/ajpregu.1998.275.6.R1803 PubMed DOI

Hoover D. B., Chang Y., Hancock J. C., Zhang L. (2000). Actions of tachykinins within the heart and their relevance to cardiovascular disease. Jpn. J. Pharmacol. 84 367–373. 10.1254/jjp.84.367 PubMed DOI

Hoover D. B., Hancock J. C. (1988). Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P. J. Auton. Nerv. Syst. 23 189–197. 10.1016/0165-1838(88)90093-8 PubMed DOI

Horackova M., Slavikova J., Byczko Z. (2000). Postnatal development of the rat intrinsic cardiac nervous system: a confocal laser scanning microscopy study in whole-mount atria. Tissue Cell 32 377–388. 10.1054/tice.2000.0126 PubMed DOI

Jarkovska D., Bludovska M., Mistrova E., Krizkova V., Kotyzova D., Kubikova T., et al. (2017). Expression of classical mediators in hearts of rats dysfunction. Can. J. Physiol. Pharmacol. 95 1351–1359. 10.1139/cjpp-2017-0060 PubMed DOI

Jubair S., Li J., Dehlin H. M., Manteufel E. J., Goldspink P. H., Levick S. P., et al. (2015). Substance P induces cardioprotection in ischemia-reperfusion via activation of AKT. Am. J. Physiol. Heart Circ. Physiol. 309 H676–H684. 10.1152/ajpheart.00200.2015 PubMed DOI PMC

Khawaja A. M., Rogers D. F. (1996). Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 28 721–738. 10.1016/1357-2725(96)00017-9 PubMed DOI

Krause J. E., Bu J. Y., Takeda Y., Blount P., Raddatz R., Sachais B. S., et al. (1993). Structure, expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes. Regul. Pept. 46 59–66. 10.1016/0167-0115(93)90012-W PubMed DOI

Kukanova B., Mravec B. (2006). Complex intracardiac nervous system. Bratisl. Lek. Listy 107 45–51. PubMed

Kuo L. E., Abe K., Zukowska Z. (2007). Stress, NPY and vascular remodeling: implications for stress-related diseases. Peptides 28 435–440. 10.1016/j.peptides.2006.08.035 PubMed DOI PMC

Lai J. P., Douglas S. D., Ho W. Z. (1998). Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86 80–86. 10.1016/S0165-5728(98)00025-3 PubMed DOI

Lai J. P., Douglas S. D., Zhao M., Ho W. Z. (1999). Quantification of substance P mRNA in human mononuclear phagocytes and lymphocytes using a mimic-based RT-PCR. J. Immunol. Methods 230 149–157. 10.1016/S0022-1759(99)00120-9 PubMed DOI

Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-Δ Δ CT method. Methods 25 402–408. 10.1006/meth.2001.1262 PubMed DOI

Maggi C. A., Patacchini R., Rovero P., Giachetti A. (1993). Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol. 13 23–93. 10.1111/j.1474-8673.1993.tb00396.x PubMed DOI

Milner P., Ralevic V., Hopwood A. M., Feher E., Lincoln J., Kirkpatrick K. A., et al. (1989). Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 45 121–125. 10.1007/BF01954843 PubMed DOI

Mistrova E., Kruzliak P., Dvorakova M. C. (2016). Role of substance P in the cardiovascular system. Neuropeptides 58 41–51. 10.1016/j.npep.2015.12.005 PubMed DOI

Nakanishi S. (1991). Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14 123–136. 10.1146/annurev.ne.14.030191.001011 PubMed DOI

Paddenberg R., Tiefenbach M., Faulhammer P., Goldenberg A., Gries B., Pfeil U., et al. (2012). Mitochondrial complex II is essential for hypoxia-induced pulmonary vasoconstriction of intra- but not of pre-acinar arteries. Cardiovasc. Res. 93 702–710. 10.1093/cvr/cvr359 PubMed DOI

Page N. M. (2004). Hemokinins and endokinins. Cell. Mol. Life Sci. 61 1652–1663. 10.1007/s00018-004-4035-x PubMed DOI PMC

Papka R. E., Urban L. (1987). Distribution, origin and sensitivity to capsaicin of primary afferent substance P-immunoreactive nerves in the heart. Acta Physiol. Hung. 69 459–468. PubMed

Pardini B. J., Patel K. P., Schmid P. G., Lund D. D. (1987). Location, distribution and projections of intracardiac ganglion cells in the rat. J. Auton. Nerv. Syst. 20 91–101. 10.1016/0165-1838(87)90106-8 PubMed DOI

Pfaffl M. W., Tichopad A., Prgomet C., Neuvians T. P. (2004). Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestkeeper–excel-based tool using pair-wise correlations. Biotechnol. Lett. 26 509–515. 10.1023/B:BILE.0000019559.84305.47 PubMed DOI

Pinto F. M., Almeida T. A., Hernandez M., Devillier P., Advenier C., Candenas M. L. (2004). mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur. J. Pharmacol. 494 233–239. 10.1016/j.ejphar.2004.05.016 PubMed DOI

Richardson R. J., Grkovic I., Anderson C. R. (2003). Immunohistochemical analysis of intracardiac ganglia of the rat heart. Cell Tissue Res. 314 337–350. 10.1007/s00441-003-0805-2 PubMed DOI

Schoborg R. V., Hoover D. B., Tompkins J. D., Hancock J. C. (2000). Increased ganglionic responses to substance P in hypertensive rats due to upregulation of NK(1) receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 R1685–R1694. 10.1152/ajpregu.2000.279.5.R1685 PubMed DOI

Sieburth D., Madison J. M., Kaplan J. M. (2007). PKC-1 regulates secretion of neuropeptides. Nat. Neurosci. 10 49–57. 10.1038/nn1810 PubMed DOI

Slavikova J., Kuncova J., Reischig J., Dvorakova M. (2003). Catecholaminergic neurons in the rat intrinsic cardiac nervous system. Neurochem. Res. 28 593–598. 10.1023/A:1022837810357 PubMed DOI

Slavikova J., Mistrova E., Klenerova V., Kruzliak P., Caprnda M., Hynie S., et al. (2016). Effects of immobilizations stress with or without water immersion on the expression of atrial natriuretic peptide in the hearts of two rat strains. Am. J. Transl. Res. 8 3148–3158. PubMed PMC

Steele P. A., Gibbins I. L., Morris J. L., Mayer B. (1994). Multiple populations of neuropeptide-containing intrinsic neurons in the guinea-pig heart. Neuroscience 62 241–250. 10.1016/0306-4522(94)90327-1 PubMed DOI

Stephenson J. A., Burcher E., Summers R. J. (1986). Autoradiographic demonstration of endothelium-dependent 125I-Bolton-Hunter substance P binding to dog carotid artery. Eur. J. Pharmacol. 124 377–378. 10.1016/0014-2999(86)90245-1 PubMed DOI

Stephenson J. A., Summers R. J. (1987). Autoradiographic analysis of receptors on vascular endothelium. Eur. J. Pharmacol. 134 35–43. 10.1016/0014-2999(87)90128-2 PubMed DOI

Tay S. S., Wong W. C. (1997). The effects of bilateral vagotomy on substance P-like immunoreactive nerves in the cardiac ganglia of the monkey (Macaca fascicularis). J. Hirnforsch. 38 125–132. PubMed

Ustinova E. E., Bergren D., Schultz H. D. (1995). Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P. Cardiovasc. Res. 30 55–63. 10.1016/S0008-6363(95)00010-0 PubMed DOI

Vinik A. I., Freeman R., Erbas T. (2003). Diabetic autonomic neuropathy. Semin. Neurol. 23 365–372. 10.1055/s-2004-817720 PubMed DOI

Walsh R. J., Weglicki W. B., Correa-de-Araujo R. (1996). Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat. Cell Tissue Res. 284 495–500. 10.1007/s004410050611 PubMed DOI

Wang L. L., Guo Z., Han Y., Wang P. F., Zhang R. L., Zhao Y. L., et al. (2011). Implication of substance P in myocardial contractile function during ischemia in rats. Regul. Pept. 167 185–191. 10.1016/j.regpep.2011.01.001 PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...